Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K D Paull

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Molecular Pharmacology|July 11, 1998
Protein-linked DNA strand breaks induced by NSC 314622, a novel noncamptothecin topoisomerase I poisonG Kohlhagen, K D Paull, M Cushman, et al.
Journal of Natural Products|November 1, 1981
Antineoplastic agents. 76. The sea urchin Strongylocentrotus droebachiensisG R Pettit, J A Hasler, K D Paull, et al.
Biochemical Pharmacology|June 22, 1993
Dual inhibition of topoisomerase II and tubulin polymerization by azatoxin, a novel cytotoxic agentE Solary, F Leteurtre, K D Paull, et al.
Anti-Cancer Drug Design|November 20, 1997
The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targetsA Monks, D A Scudiero, G S Johnson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
In vitro assessment of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide, a DNA-intercalating antitumour drug with reduced sensitivity to multidrug resistanceG J Finlay, E Marshall, J H Matthews, et al.
Journal of Medicinal Chemistry|February 1, 1982
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastasesR K Robins, P C Srivastava, V L Narayanan, et al.
The Journal of Organic Chemistry|May 1, 1970
Bufadienolides. 7. Synthesis of 3-beta-acetoxy-5-alpha,14-alpha-bufa-20,22-dienolideG R Pettit, D C Fessler, K D Paull, et al.
Biochemical Pharmacology|June 1, 1985
5-(N-phenylcarboxamido)-2-thiobarbituric acid (NSC 336628), a novel potential antitumor agentA D Brewer, J A Minatelli, J Plowman, et al.
Biochemical and Biophysical Research Communications|August 14, 1992
Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cellsH N Jayaram, K Gharehbaghi, N H Jayaram, et al.
Journal of Pharmaceutical Sciences|September 1, 1972
Synthesis of 9-(3,4-dimethoxyphenoxy)-1,2,10-trimethoxyaporphineK D Paull, R R Engle, L M Twanmoh, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Molecular Pharmacology|July 11, 1998
Protein-linked DNA strand breaks induced by NSC 314622, a novel noncamptothecin topoisomerase I poisonG Kohlhagen, K D Paull, M Cushman, et al.
Journal of Natural Products|November 1, 1981
Antineoplastic agents. 76. The sea urchin Strongylocentrotus droebachiensisG R Pettit, J A Hasler, K D Paull, et al.
Biochemical Pharmacology|June 22, 1993
Dual inhibition of topoisomerase II and tubulin polymerization by azatoxin, a novel cytotoxic agentE Solary, F Leteurtre, K D Paull, et al.
Anti-Cancer Drug Design|November 20, 1997
The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targetsA Monks, D A Scudiero, G S Johnson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
In vitro assessment of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide, a DNA-intercalating antitumour drug with reduced sensitivity to multidrug resistanceG J Finlay, E Marshall, J H Matthews, et al.
Journal of Medicinal Chemistry|February 1, 1982
2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastasesR K Robins, P C Srivastava, V L Narayanan, et al.
The Journal of Organic Chemistry|May 1, 1970
Bufadienolides. 7. Synthesis of 3-beta-acetoxy-5-alpha,14-alpha-bufa-20,22-dienolideG R Pettit, D C Fessler, K D Paull, et al.
Biochemical Pharmacology|June 1, 1985
5-(N-phenylcarboxamido)-2-thiobarbituric acid (NSC 336628), a novel potential antitumor agentA D Brewer, J A Minatelli, J Plowman, et al.
Biochemical and Biophysical Research Communications|August 14, 1992
Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cellsH N Jayaram, K Gharehbaghi, N H Jayaram, et al.
Journal of Pharmaceutical Sciences|September 1, 1972
Synthesis of 9-(3,4-dimethoxyphenoxy)-1,2,10-trimethoxyaporphineK D Paull, R R Engle, L M Twanmoh, et al.
Pageof 6